Investigation of genetic predictors of the response to SSRI treatment in patients with panic disorder.
Phase of Trial: Phase IV
Latest Information Update: 17 Jun 2016
At a glance
- Drugs Escitalopram (Primary)
- Indications Major depressive disorder; Panic disorder
- Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
- 05 Sep 2015 Status changed from recruiting to completed as per European Clinical Trials Database record.
- 26 Jul 2011 New trial record